MyMeds&Me, a provider of SaaS, web-based adverse event and product quality capture solutions for life sciences, announced its collaboration with Oracle Health Sciences to provide the Reportum® solution to Oracle Argus safety customers.
MyMeds&Me, a provider of SaaS, web-based adverse event and product quality capture solutions for life sciences, announced its collaboration with Oracle Health Sciences to provide the Reportum® solution to Oracle Argus safety customers. This collaboration allows access to the innovative Reportum® solution providing a standardized method of capturing complete Adverse Event data at source, from all reporter types. The Reportum® solution provides web-based safety data capture at initial reporter interaction and supports direct reporting by consumers, streamlining a traditionally paper-based activity that can generate duplicate data entry.
Read the full release here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Carvykti Significantly Boosts Survival, MRD Negativity in Relapsed Multiple Myeloma
December 10th 2024Phase III CARTITUDE-4 trial shows Carvykti significantly improves minimal residual disease negativity rates, progression-free survival, and overall survival compared to standard therapies for patients with relapsed or refractory multiple myeloma, especially when used earlier in treatment.